Tissue engineering combines the use of cells, engineering materials, and physicochemical factors to improve or replace the biological functions of damaged tissues or organs.
We believe this rapidly moving field promise many more to come, and progress in this research will facilitate the optimization of in vitro differentiation protocols, which can finally benefit the better design of cell engineering using MSCs.
The current efforts focus on understanding murine reconstitution following transplantation, use of a peptide polymer to block MHC class II recognition of minor histocompatibility antigens, use of T cell engineering to prevent graft-versus-host disease at the same time preserving a graft-versus-malignancy effect.
This special issue set out to demonstrate the current developments and future perspectives in the use of cell microenvironment engineering and monitoring in producing functional tissues.
In silico analysis of microRNA-mediated regulation of these pathways resulted in a high-priority list of microRNAs for use as cell engineering targets or biomarkers, such as microRNA-17-92 microRNA-17-92 microRNA-17-92
The use of cell sheets for tissue engineering applications has considerable advantages over single cell seeding techniques.
Osteoinductive pretreatment of human mesenchymal stromal cells (hMSCs) has been widely accepted in bone tissue engineering before the use of cell transplantation; however, the mechanisms by which osteoinductive medium (OIM) enhances osteoblastic differentiation are not well understood.
In this context, the use of cell-seeded biomaterials for tissue engineering of the IVD has been recently investigated [ 7, 8].
This review will focus on the functional approach of using biomaterial scaffold materials as cell carriers for musculoskeletal applications, as well as the use of cell-based gene therapy for tissue engineering and regeneration.
Tissue engineering, with the use of cells and scaffolds, has important clinical application in regenerative medicine.
